Validity of the Disabilities of the Arm, Shoulder and Hand patient-reported outcome measure (DASH) and the Quickdash when used in Dupuytren’s disease-Reference-Cited by-同舟云学术

Validity of the Disabilities of the Arm, Shoulder and Hand patient-reported outcome measure (DASH) and the Quickdash when used in Dupuytren’s disease

Published:2015-08-25 Issue:6 Volume:41 Page:589-599
ISSN:1753-1934
Container-title:Journal of Hand Surgery (European Volume)
language:en
Short-container-title:J Hand Surg Eur Vol

Author:

Rodrigues J.¹,Zhang W.²,Scammell B.²,Russell P.³,Chakrabarti I.⁴,Fullilove S.⁵,Davidson D.⁶,Davis T.²

Affiliation:

1. Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Nuffield Orthopaedic Centre, Oxford, UK

2. Division of Rheumatology, Orthopaedics and Dermatology, University of Nottingham & Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK

3. Pulvertaft Hand Centre, Royal Derby Hospital, Uttoxeter New Road, Derby, UK

4. Rotherham General Hospital, Rotherham, UK

5. Derriford Hospital, Plymouth, UK

6. St John’s Hospital at Howden, Livingston, UK

Abstract

This study investigated aspects of the validity and reliability of the 30-item Disabilities of the Arm, Shoulder and Hand patient-reported outcome measure (DASH) and its relationship with the shorter 11-item QuickDASH in patients with Dupuytren’s disease. Seven hundred and fifty-nine DASH questionnaires were studied, covering pre- and postoperative patients undergoing different treatments for Dupuytren’s disease. Items related to pain rose early after treatment before returning to baseline, suggesting that studying pain is relevant during postoperative recovery. Across all 759 sets of responses, the QuickDASH agreed closely with the DASH. In exploratory factor analysis, the DASH was not unidimensional, questioning the validity of the DASH summary score in Dupuytren’s disease. Further validation of existing PROMs for use in Dupuytren’s disease is needed. These data suggest that pain is a relevant symptom to study during postoperative recovery following treatment for Dupuytren’s disease. Level of evidence: III.

Publisher

SAGE Publications

Subject

Surgery

Link

http://journals.sagepub.com/doi/pdf/10.1177/1753193415601350

Reference39 articles.

1. A review of the classification of Dupuytren’s disease

2. Optimal functional outcome measures for assessing treatment for Dupuytren’s disease: a systematic review and recommendations for future practice

3. Unité Rhumatologique des Affections de la Main (URAM) scale: Development and validation of a tool to assess Dupuytren's disease-specific disability

4. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant Treatment with Celecoxib after Collagenase Injection for Dupuytren Contracture: A Double-Blind Randomised Controlled Trial;The Journal of Hand Surgery (Asian-Pacific Volume);2024-07-12

2. The construct validity and internal consistency of QuickDASH in pediatric patients with upper extremity fractures;Acta Orthopaedica;2024-04-30

3. Modified Scoring of the QuickDASH Can Achieve Previously-unattained Interval-level Measurement in Dupuytren Disease and Carpal Tunnel Syndrome;Plastic and Reconstructive Surgery - Global Open;2024-02

4. Psychometric sensitivity analyses can identify bias related to measurement properties in trials that use patient-reported outcome measures: a secondary analysis of a clinical trial using the disabilities of the arm, shoulder, and hand questionnaire;Journal of Clinical Epidemiology;2023-11

5. Responsiveness of the Arabic Quick Disabilities of the Arm, Shoulder and Hand in Patients with Upper Extremity Musculoskeletal Disorders;Healthcare;2023-09-10